To clarify the alternative mechanisms to vitamin E (VE) regulating lipid peroxide accumulation in the liver after docosahexaenoic acid (DHA) ingestion, we examined the relationship between the DHA-induced lipid peroxide formation and induction of the xenobiotic transporters, Ral-binding GTPase-activating protein (RalBP1) and multidrug resistance-associated proteins 1, 2 and 3 (MRP1-3), in the liver of rats fed with DHA. The test diets contained DHA and linoleic acid (LA) (8.7% and 2.1% of total energy, respectively) with different levels of dietary VE (normal and low: 68 and 7.7 mg of alpha-tocopherol equivalent per kg diet, respectively), and the control diet contained LA alone (11.5% of total energy). The rats were fed with these experimental diets for 14 d. The proportions of DHA in the liver, kidney and heart were higher in the DHA-fed groups than in the LA-fed group. The tissue thiobarbituric acid values as an index of lipid peroxidation were also significantly higher in the DHA-fed groups, but the value did not differ between the DHA-fed groups with different VE levels. In the liver, there were no significant differences in the glutathione S-transferase (GST) and aldehyde dehydrogenase (ALDH) activities or in the expression of GST M2, RalBP1, MRP1 and MRP2 mRNA. However, the obvious induction of expression of liver MRP3 mRNA and tendency to produce the protein were recognized after DHA ingestion. This study is the first to report the gene expression of MRP3 by DHA ingestion. There might exist, therefore, some relationship between the DHA intake and MRP3 induction in regulating lipid peroxide accumulation in the liver.
1-4)
However, DHA itself is very prone to lipid peroxidation because of its unstable chemical structure with six double bonds. Peroxidation of lipids is associated with oxygen toxicity and causes degeneration of cell membranes and other lipid-containing structures, and thus is closely associated with pathologies. 5) We have shown in previous studies that the ingestion of DHA, [6] [7] [8] [9] [10] as with the ingestion of fish oil, [11] [12] [13] [14] enhanced the susceptibility of rat liver and kidney to lipid peroxidation and increased the requirement for vitamin E (VE). This enhanced lipid peroxidation was a function of the dietary DHA level and was thought to be attributable to the replacement of membrane fatty acids with highly unsaturated DHA.
On the other hand, the main cellular chain-breaking antioxidants, VE, ascorbic acid, glutathione (GSH), uric acid, carotenoids, ubiquinone, polyphenols, etc., 15) suppress lipid peroxide formation in tissues, and VE acts as a major lipophilic membrane antioxidant. Additionally, ascorbic acid and GSH are known to potentiate the reductive recycling of VE, leading to augmentation of its antioxidative activity. 16, 17) However, high levels of dietary VE 7, 9) and ascorbic acid 18) failed to suppress the DHA-induced formation of lipid peroxide in tissues. This was also the case with fish oil ingestion involving a higher intake of VE. 19, 20) Accordingly, we have proposed that the antioxidative action of VE and ascorbic acid was limited. Additionally, the ingestion of DHA did not increase the liver glutathione reductase or glutay To whom correspondence should be addressed. Tel: +81-745-52-0451; Fax: +81-745-23-3577; E-mail: k-kubo@nara-su.ac.jp * Present address: The Nisshin Oillio Group Ltd., 1-Banchi, Shinmei-cho, Yokosuka-shi, Kanagawa 239-0832, Japan Abbreviations: ALDH, aldehyde dehydrogenase; CAR, constitutive androstane receptor; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSH, glutathione; GST, glutathione S-transferase; HNE, 4-hydroxy-2-nonenal; LA, linoleic acid; MRP1-3, multidrug resistance-associated proteins 1, 2 and 3; PUFAs, polyunsaturated fatty acids; PXR, pregnane X receptor; RalBP1, Ralbinding GTPase-activating protein; RXR, retinoid X receptor; TBA, thiobarbituric acid; VE, vitamin E thione peroxidase activity, even though the tissue lipid peroxide levels were higher in the DHA-fed rats. 9, 10) Nevertheless, DHA ingestion did not increase the endproducts of lipid peroxidation, such as lipofuscin, in the liver of rats fed with the physiological requirement level of VE, and no tissue parenchymal cell injury was apparent at this VE status. 7, 9, 10) This means that some alternative mechanisms to those induced by antioxidants and antioxidative enzymes were induced to suppress the accumulation of lipid peroxides after DHA ingestion.
It has recently been demonstrated that Ral-binding GTPase-activating protein (RalBP1 or RLIP76), which is a xenobiotic transporter, 21) could catalyze the ATPdependent transport of GSH conjugates of the degradation products of lipid peroxidation such as 4-hydroxy-2-nonenal (HNE). 22, 23) On the other hand, multidrug resistance-associated proteins (MRPs) have also been shown to transport various xenobiotics, including HNE. [24] [25] [26] [27] To clarify the other alternative mechanisms to that of VE regulating the accumulation of lipid peroxide in the liver after DHA ingestion, we assigned DHA-fed groups with different VE contents and investigated the relationship between the DHA-induced lipid peroxide formation and expression of the four xenobiotic transporters, RalBP1, MRP1, MRP2 and MRP3, in the liver of rats.
Materials and Methods
Animals and diets. The experimental procedures used in this study met the guidelines of the animal handling committee of the Incorporated Administrative Agency, National Institute of Health and Nutrition (Tokyo, Japan).
Male Sprague-Dawley rats (CLEA Japan, Tokyo, Japan) at 5 weeks of age and weighing 100-124 g were housed individually in stainless-steel wire-bottomed cages at a constant temperature of 22 AE 1 C and humidity of 50-60% with a 12-h light/dark cycle. The composition of the experimental diets, based on the AIN-76 purified diet for rats, 28, 29) is shown in Table 1 . DHA ethyl esters (919 g/kg purity) prepared from the orbital fat of tuna were donated by Maruha Corporation (Tsukuba, Japan). To prevent the autoxidation of DHA in the diets, the diet was prepared beforehand without DHA and stored at À20 C until needed. The DHA was stored at À80 C and mixed with the diet every day immediately before feeding. The VE concentration as the RRR-alpha-tocopherol equivalent of the LA (18:2n-6) diet group was 68 mg/kg, and those of the test diets (DHA groups) were 7.7 and 68 mg/kg, respectively. The relative biological activity of RRR-alpha-, RRR-beta-, RRR-gamma-and RRR-delta-tocopherols were assumed to be 100, 40, 10 and 1, respectively, in the calculation. 31) All-rac-alpha-tocopheryl acetate (>99% pure), purchased from Kawai Pharmaceutical (Tokyo, Japan), was used to adjust the VE concentration in the diets. The fatty acid composition (g/100 g of fatty acids) of dietary lipids is also indicated in Table 1 . The proportions of total PUFAs were almost the same in the LA and two DHA diet groups. The control lipid, devoid of DHA, contained 52.2% LA (11.5% of total dietary energy). The test lipids contained 38.6% DHA (8.7% of total dietary energy) and 11.0% LA (2.1% of total dietary energy) as an essential fatty acid of the n-6 series.
After the rats had been fed on a basal diet containing 50 g of high-oleic safflower oil per kg for 5 d, 6 rats per group were fed with the experimental diets for 14 d. Food and water were provided ad libitum. During the supplementation period, each diet was made available to the rats in the evening and was removed the next morning. After being deprived of food overnight, the rats were killed by cardiac puncture. The tissues were promptly excised, washed with isotonic saline (9 g of NaCl/l), and weighed. Part of the liver was then perfused with ice-cold isotonic saline via the portal vein, and the rest was immediately stored in an RNA The energy density of all diets was 17.4 MJ/kg of diet (4,160 kcal/kg), using the Atwater energy factors for the energy calculation. 30) Abbreviations used: AA, arachidonic acid; alpha-LN, alpha-linolenic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid; PUFA, polyunsaturated fatty acid; VE, vitamin E. 2 RRR-alpha-tocopherol equivalent. 3 The basic components of the diet given to all groups were as follows: casein, 200.0 g; DL-methionine, 3.0 g; cornstarch, 150.0 g; sucrose, 225.0 g; glucose, 225.0 g; cellulose powder, 50.0 g; AIN-76 vitamin mixture, 28, 29) 10.0 g; AIN-76 mineral mixture, 28) 35.0 g; choline bitartrate, 2.0 g. 4 The fat energy percentage was 21.6% of the total energy. 5 DHA ethyl esters prepared from the ethyl esters of the orbital fat of tuna were used and the purity was 91.9%. stabilization solution, RNAlater (Ambion, Austin, TX, USA), to preserve the RNA in the liver, before being stored at À80 C for total RNA extraction. The liver, kidney and heart samples were stored at À80
C until needed for analysis.
Fatty acid composition analysis. Total lipids in the liver, kidney and heart were extracted according to the method of Folch et al.
32)
Fatty acid methyl esters of the dietary lipids and total tissue lipids were prepared according to Sekine et al.
18)
The methyl esters were analyzed by gas-liquid chromatography with a flame ionization detector (GC-18A, Shimadzu Kyoto, Japan).
Thiobarbituric acid value analysis. The tissue thiobarbituric acid (TBA) value as an index of lipid peroxidation was measured according to the method of Ohkawa et al. 33) with a minor modification, in which butylated hydroxytoluene was added to the reaction mixture at a final concentration of 2.25 mmol/l. The TBA value is expressed in terms of the malondialdehyde equivalent.
VE analysis. The VE (alpha-tocopherol) levels in the dietary lipids and tissues were analyzed according to the HPLC method of Saito et al.
34)
Enzyme assays. The aldehyde dehydrogenase (ALDH) activity was determined according to the method of Pietruszko and Yonetani, 35) while the glutathione Stransferase (GST) activity was determined according to the method of Warholm et al. 36) One unit of GST activity is defined as 1 mmol of S-2,4-dinitrophenylglutathione formed per min from 1 mM GSH and 1 mM 1-chloro-2,4-dinitrobenzene. The protein concentration was determined with a Protein Assay Rapid kit (Wako Pure Chemical Industries, Osaka, Japan).
RNA extraction and RT-PCR. Total RNA was extracted from rat liver with the Trizol reagent (Life Technologies, Rockville, MD, USA) according to the instructions provided by the manufacturer, before being stored at À80
C. The concentration of total RNA was measured with GeneQuant Pro (Amersham Biosciences, Piscataway, NJ, USA), the 260/280 ratio of RNA being 1.8 to 2.0. The extracted RNA was dissolved in diethylpyrocarbonate-treated water 37) and then reversetranscribed. Reverse-transcription was performed with a First Strand cDNA Synthesis kit for RT-PCR (AMV) (Roche Diagnostics, Indianapolis, IN, USA) according to the manufacturer's instructions. Two micrograms of total RNA was reverse-transcribed by AMV reverse transcriptase with random hexamers as primers, and 40 ml of the new cDNA was synthesized.
Oligonucleotide primers. Primers were designed from the published sequences of rat MRP1, MRP2, MRP3, GST M2 (= GST A4), RalBP1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (DDBJ/ EMBL/GenBank). All primer sequences are shown in Table 2 .
Real-time PCR. Real-time PCR was performed with a Light Cycler (Roche Diagnostics, Mannheim, Germany) in Light Cycler capillaries with a commercially available master mix (Light Cycler Fast Start DNA master SYBR Green I; Roche Diagnostics, Penzberg, Germany) containing Taq DNA polymerase and SYBRGreen I deoxyribonucleoside triphosphates. After adding the primers (final concentration of 0.5 mM), MgCl 2 (3 mM, or 2 mM for RalBP1) and template DNA to the master mix, 40 cycles of denaturation (94 C for 10 s), annealing (68-58 C at À0:5 C/cycle for 10 s) and extension (72 C for 13 s) were performed. The PCR products were analyzed by using the Light Cycler Roche program and Light Cycler Software version 3.5. The sample with an unknown concentration and the standard of the PCR product with the known concentration were simultaneously amplified. Before the data analysis, À3 , Â10 À2 ) of the PCR products with known concentration. The relative value of the number of copies of the transcription product was calculated by using these external standard curves, and the mRNA levels of MRP1, MRP2, MRP3, GST M2 and RalBP1 are expressed as the relative values to GAPDH mRNA.
Western blot analysis. We used pooled samples from 6 rats for the western blot analysis. The protein concentrations were determined with a Protein Assay Rapid kit (Wako Pure Chemical Industries, Osaka, Japan). Thirty mg (MRP1 and MRP2) or 50 mg (MRP3) of the crude proteins were fractionated in a 7.5% polyacrylamide slab gel (ReadyGel J; Bio-Rad Laboratories, CA, USA) and transferred on to a polyvinylidene difluoride membrane (Immobilon-P; Millipore, Billerica, MA, USA) by electro-blotting. After blocking for 1 h, the membrane was incubated for 2 h at room temperature with the primary antibody at the following appropriate dilution: anti-MRP1 (N-19), 1:10,000 dilution (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-cMOAT/MRP2 monoclonal antibody (M 2 III-6), 1:40 dilution (Alexis, Grünberg, Germany); and anti-MRP3 (C-18), 1:5000 dilution (Santa Cruz Biotechnology). After washing with a 10 mM Tris-Cl buffer (pH 7.6) containing 150 mM NaCl and 0.05% Tween 20, each membrane was incubated for 1 h at room temperature with the corresponding horseradish peroxidase-conjugated secondary antibody: rabbit anti-goat IgG, 1:10,000 dilution (Sigma-Aldrich, St. Louis, MO, USA) for MRP1 and MRP3; and goat anti-mouse IgG, 1:40,000 dilution (Sigma-Aldrich) for cMOAT/MRP2. After the membranes had been washed with the Tris-Cl buffer just mentioned, MRP1, cMOAT/MRP2 and MRP3 were detected by using an enhanced chemiluminescence (ECL) reagent (ECL Plus Western Blotting Detection System; Amersham, Little Chalfont, Buckinghamshire, UK), the resulting autoradiographs being exposed to medical X-ray film (Fuji Photo Film, Tokyo, Japan) and visualized with the Scion Image program (Scion Corporation, Frederick, MD, USA).
Statistical analyses. Each data value is expressed as the mean AE standard deviation (SD). The data were first analyzed by the F-test for homogeneity of variance with a significance level of 5%. If the test revealed homogeneity of variance, the significance of the difference between two groups was assessed by using Student's t-test. In the case of heterogeneity of variance, significant differences between two groups were assessed by using the Aspin-Welch t-test. The difference is considered significant at P < 0:05. All calculations were performed with StatLight software (Yukms Co., Tokyo, Japan).
Results

Food intake, body weight gain and fatty acid composition of the tissue total lipids
The rats consumed 14.4-17.9 g food/d and gained 5.5-7.6 g/d during the 14 d of the experimental period. The food intake was significantly lower in the DHA group (14:8 AE 1:1 g/d) than in the LA group (17:9 AE 1:0 g/d), but did not differ significantly between the DHA group and DHA group with low VE (DHA-lowVE group; 14:4 AE 1:2 g/d). The body weight gain was also significantly lower in the DHA group (5:8 AE 0:5 g/d) than in the LA group (7:6 AE 0:7 g/d), but did not differ significantly between the DHA group and DHA-lowVE group (5:5 AE 0:9 g/d). The relative weights of tissues (liver, kidney and heart), however, did not differ significantly among any of the treatment groups (data not shown).
We investigated the incorporation of DHA into the tissues by analyzing the fatty acid composition of the tissue total lipids. The major PUFA compositions of the total lipids in the liver, kidney, and heart are shown in Table 3 . In all the tissues, the proportions of LA, arachidonic acid (20:4n-6; AA) and 22:5n-6 were significantly lower in the DHA group than in the LA group, but there were no significant differences in these compositions between the two DHA-fed groups. The proportions of EPA and DHA were higher in the DHA-fed groups than in the LA group, but the proportions of these PUFAs between the two DHAfed groups were not significantly different, except in the liver, where the proportion of DHA was lower in the low-VE group.
TBA values
The TBA values in all tissues were significantly higher in the DHA group than in the LA group, but the value did not differ between the DHA groups with different dietary VE level (Fig. 1A) .
VE levels, antioxidative enzyme activities, and expression of GST M2 mRNA
We measured VE (alpha-tocopherol) as the major lipophilic membrane antioxidant, the activities of the two antioxidative enzymes, ALDH and GST, and the expression of GST M2 mRNA. The liver VE level in the DHA group was significantly lower than that in the LA group, and the level was significantly lower in the DHAlowVE group than that in the DHA group (Fig. 1B) . On the other hand, the VE levels of the kidney and heart did not differ significantly between the LA and DHA groups, but they were significantly lower in the DHAlowVE group than those in the DHA group (Fig. 1B) . In respect of the activities of liver ALDH and GST, there were no significant differences between any of the treatment groups (Table 4 ). The expression of liver GST M2 mRNA tended to be induced more in the DHA group than that in the LA group, more so in the DHA-lowVE Each data value is expressed as the mean AE SD (n ¼ 6 rats for each group). AA, arachidonic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid; VE, vitamin E. Ã P < 0:05 compared to the LA group. ÃÃ P < 0:05 compared to the DHA group.
TBA value
(nmol MDA/g of tissue) Each data value is expressed as the mean AE SD (n ¼ 6 in each group). LA, linoleic acid group; DHA, docosahexaenoic acid group; DHAlowVE, DHA group with low vitamin E.
Ã P < 0:05 compared to the LA group. ÃÃ P < 0:05 compared to the DHA group. Each data value is expressed as the mean AE SD (n ¼ 6 rats for each group). ALDH, aldehyde dehydrogenase; DHA, docosahexaenoic acid; GST, glutathione S-transferase; LA, linoleic acid; VE, vitamin E.
group, although these differences were not significant (Fig. 2) .
Expression of liver xenobiotic transporters
There was no significant difference in the expression of liver RalBP1 mRNA between any of the treatment groups (Fig. 2) . Figure 3A shows the average protein expression of pooled samples from all six animals. The expression of liver MRP1 mRNA and production of protein tended to be induced more in the DHA group than in the LA group, but the difference was not significant (Fig. 3) . On the other hand, the expression of liver MRP2 mRNA and production of protein tended to be reduced more in the DHA group than in the LA group, although there were no significant differences among the treatment groups (Fig. 3) . The expression of liver MRP3 mRNA and production of protein were significantly higher in the DHA group than in the LA group, and were further induced in the DHA-lowVE group than in the DHA group, although the difference was not significant (Fig. 3) .
Discussion
The proportion of DHA in the tissues examined was significantly higher in the DHA-fed groups than in the LA-fed group, even with a short feeding period of two weeks (Table 3) , which is consistent with the results of our previous studies for a longer feeding period of one month. 9, 18, 38) The TBA values in the tissues were also significantly higher in the DHA group than in the LA group (Fig. 1A) . However, in the DHA-fed groups, low dietary VE decreased the tissue VE levels (Fig. 1B) , but did not increase the TBA values (Fig. 1A) . This observation can be partly explained by the fact that the tissue VE levels were not completely depleted in the low VE group. Moreover, we observed in the present study that the ingestion of DHA did not increase the activities of the liver antioxidative enzymes, GST and ALDH (Table 4) .
These phenomena, together with previous observations described in the Introduction section, cannot be explained merely by the levels of antioxidants and the activities of the antioxidative enzymes. Therefore, some alternative mechanisms other than those caused by the antioxidants and antioxidative enzymes might have regulated the accumulation of lipid peroxides as indicated by the TBA-reactive substances in the liver of the rats fed with DHA. To clarify this, we investigated the expression of the four liver xenobiotic transporters, RalBP1 and MRP1, 2 and 3.
Studies with various cell lines and erythrocytes in humans have indicated that the transport of most (about 2/3) GSH conjugates with HNE (GS-HNE) was catalyzed by the ATP-dependent xenobiotic transporter, RalBP1. 22, 23) Renes et al. 24) have shown that MRP1 also mediated the transport of GS-HNE, suggesting a physiological role of MRP1 in normal cells. The expression of MRP1 and -glutamylcysteine synthetase genes is regulated by oxidative stress. 39) We have reported that the level of GSH in the liver was increased All data were normalized to the GAPDH mRNA levels and each is expressed as the mean AE SD (n ¼ 6 rats for each group). LA, linoleic acid group; DHA, docosahexaenoic acid group; DHAlowVE, DHA group with low vitamin E. The mRNA levels were normalized to the GAPDH mRNA levels and each is expressed as the mean AE SD (n ¼ 6 in each group). LA, linoleic acid group; DHA, docosahexaenoic acid group; DHA-lowVE, DHA group with low vitamin E.
Ã P < 0:05 compared to the LA group.
by DHA ingestion. 7, 9, 10) In the present study, however, there was no significant change in the gene expression of RalBP1 (Fig. 2) and MRP1 (Fig. 3B) . GSH is particularly important because it also serves as the substrate for the two major antioxidative enzymes, glutathione peroxidase and GST. GST is the major conjugative enzyme involved in the detoxification of electrophilic compounds and products of oxidative stress. The alphaand Mu-class rat GSTs catalyze GS-HNE preferentially. 40) Of the Mu-class rat GSTs, M2-2 is the most efficient. 40) However, there was no significant change in the expression of GST M2 mRNA (Fig. 2) . On the other hand, Tatebe et al. 41) have reported that the expression of the MRP1 and MRP3 genes was induced with expression of the -glutamylcysteine synthetase gene. In the present study, the obvious induction of expression of liver MRP3 mRNA and the tendency to produce the protein could be recognized after DHA ingestion (Figs. 3A, B) . This result is consistent with another report that MRP3 was the most sensitive among the MRP1-6 genes to induction by prooxidants. 42) MRP1 and 3 are located on the basolateral membrane of polarized cells, 43, 44) whereas MRP2 is localized on the apical membrane (canalicular in the liver), which implies that, in the liver, MRP2-mediated transport leads to increased excretion into bile, but MRP1-and MRP3-mediated transport into blood leads to increased excretion into urine. Our results suggest the transport of liver-toxic products generated during DHA-induced lipid peroxidation into the blood.
Rat hepatic MRP3 mRNA is induced by the activation of two xenobiotic receptors, the constitutive androstane receptor (CAR, NR1I3) 45) and pregnane X receptor (PXR, NR1I2), 46) thus enhancing the vectoral excretion of some phase II metabolites from the liver to the blood. If such toxic products as HNE and 4-hydroxy-2-hexenal (HHE) exist in the TBA-reactive substances formed by DHA ingestion, it is probable that the expression of MRP3 mRNA and protein would be induced to protect the body against toxic oxidation products. PXR and CAR have been shown to heterodimerize with the retinoid X receptor (RXR) and increase transcription. 47) Due to its functions as the obligate heterodimeric partner, RXR is essential for PXR and CAR activity. DHA has been identified as an endogenous ligand for RXR, 48) and thus this also might enhance the expression of the MRP3 gene. We have been conducting studies to reveal the precise mechanisms for the interrelation between DHA ingestion and MRP3 induction.
The present study is the first to report the gene expression of MRP3 by DHA ingestion. We conclude that there might exist some relationship between the DHA intake and MRP3 induction in regulating lipid peroxide accumulation in the liver.
